dangers of taking glp-1 Medications: Everything You Need to Know The Hidden Dangers of GLP-1

The development of GLP-1 and related peptides shows how quickly metabolic research is changing

doi:10.1111/obr.12334 Dutton WP, Paddu N, Braddock A, Sweeney B

A clinical trial of sitagliptin in a small sample of patients with impaired glucose tolerance and mild T2DM found significant reductions in carotid intimal thickness in sitagliptin compared with diet control alone [122]

Counsel patients regarding the potential risk for MTC with the use of Ozempic and inform them of symptoms of thyroid tumors (e.g., a mass in the neck, dysphagia, dyspnea, persistent hoarseness)

batch traceable Tamper-evident seal

Those who have other qualifying conditions such as type 2 diabetes could retain coverage, but others will have to find alternative medications that some say arent as effective